lactulose hepatic encephalopathy
Selected indexed studies
- Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis. (PLoS One, 2022) [PMID:35471992]
- Hepatic Encephalopathy in Children. (Indian J Pediatr, 2024) [PMID:37310582]
- Diagnosis and Management of Cirrhosis and Its Complications: A Review. (JAMA, 2023) [PMID:37159031]
_Worker-drafted node — pending editorial review._
Connections
lactulose hepatic encephalopathy is a side effect of
Sources
- Rifaximin treatment in hepatic encephalopathy. (2010) pubmed
- Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis. (2022) pubmed
- Hepatic encephalopathy - recent advances in treatment and diagnosis. (2023) pubmed
- Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. (2014) pubmed
- Hepatic Encephalopathy in Children. (2024) pubmed
- Diagnosis and Management of Cirrhosis and Its Complications: A Review. (2023) pubmed
- Hepatic Encephalopathy. (2016) pubmed
- Hepatic encephalopathy in dogs and cats. (2016) pubmed
- Beyond Lactulose: Treatment Options for Hepatic Encephalopathy. (2019) pubmed
- Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review. (2019) pubmed